Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07104396 · ClinicalTrials.gov registry record
Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics
A clinical trial of Substance Use Disorders (SUDs), sponsored by Square2 Systems.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07104396 is a study of Substance Use Disorders (SUDs) that is actively recruiting participants, run by Square2 Systems. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07104396, a study of Substance Use Disorders (SUDs), is actively recruiting participants, sponsored by Square2 Systems.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Conditions Studied
Interventions
- OTHER Cogito digital therapeutics development platform
Study Locations (1)
New Hampshire
- Square 2 Systems - Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-02 |
| Est. Completion | 2025-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07104396
The ClinicalTrials.gov registry entry for NCT07104396 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Square2 Systems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Use Disorders (SUDs) appearing as the primary indexed condition, and to 1 intervention - of which Cogito digital therapeutics development platform is the first listed.
NCT07104396 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT07104396 about?
NCT07104396 is a clinical study titled "Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics". This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with...
What is the current status of trial NCT07104396?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-07-02. Estimated completion is 2025-08-31.
What conditions does trial NCT07104396 study?
This clinical trial studies the following conditions: Substance Use Disorders (SUDs).
What interventions are being tested in trial NCT07104396?
The interventions under investigation include: Cogito digital therapeutics development platform (OTHER).
Who is sponsoring clinical trial NCT07104396?
This trial is sponsored by Square2 Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07104396 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.